To find VirG proteins with altered properties, the virG gene was mutagenized. Random chemical mutagenesis of single-stranded DNA containing the Agrobaterium tumaiens virG gene led with high frequency to the inactivation of the gene. Sequence analysis showed that 29%o of the mutants contained a virG gene with one single-base-pair substitution somewhere in the open reading frame. Thirty-nine different mutations that rendered the VirG protein inactive were mapped. Besides these inactive mutants, two mutants in which the ir genes were active even in the absence of acetosyringone were found on indicator plates. A VirG protein with an N54D substitution turned out to be able to induce a virB-lacZ reporter gene to a high level even in the absence of the inducer acetosyringone. A VirG protein with an I77V substitution exhibited almost no
induction in the absence of acetosyringone but showed a maximum induction level already at low concentrations of acetosyringone.
Crown gall disease on dicotyledonous plants is caused by infectious Agrobacterium strains, which transfer part of their tumor-inducing (Ti) plasmid (the T-DNA) to the plant cell nucleus (for recent reviews, see references 10, 19, 51, and 55) . This system of DNA transfer is coordinated by proteins which are encoded by the virulence regulon located on the Ti plasmid. Expression of the virulence genes is regulated by the VirA and VirG proteins under the influence of plant phenolic compounds like acetosyringone (AS). As members of the family of two-component regulatory systems (35, 46) , the VirA protein acts as a transmembrane protein kinase (22, 29, 53) and the VirG protein as an effector or response regulator (38, 50, 52) . It is thought that upon induction by phenolic compounds, which are secreted by wounded plant cells, the VirA protein is autophosphorylated on a conserved histidine residue (12, 15) . The phosphate group is transferred to a conserved aspartic acid residue of the VirG protein, which then becomes activated (14, 40) . Certain monosaccharides act synergistically with phenolic compounds in vir gene induction (1, 3) . The gene product of the chromosomal chvE gene probably binds monosaccharides and then enhances vir gene induction by binding to the periplasmic domain of VirA (3, 42, 43) . The class of response regulator proteins consists of proteins for which the N-terminal part regulates the activity of the Cterminal part, depending on the phosphorylation status. It is thought that by phosphorylation of the N-terminal part of VirG, the C-terminal part of the protein gains a much higher affinity for binding to vir promoters. Binding of the VirG protein to the vir boxes located in the promoter regions of all the vir operons eventually leads to activation of transcription (16, 30, 36, 38) .
To study the structure-function relationship of the VirG protein, random single-base-pair mutations were introduced PCR, and a virG cassette gene was constructed for identification of the mutations. A screening procedure was developed to identify inactive as well as constitutive mutants. This report describes the method of mutagenesis, the identification of the mutations introduced, and the characterization of two constitutive mutants isolated.
(Part of this work was published in the Ph.D. thesis of K.W.R., Leiden University, Leiden, The Netherlands, 1992.)
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are described in Table 1 . LBA2602 was constructed as follows. The 1.2-kb PstI fragment from pRAL3244 (47), containing DNA located 3' downstream of the virG gene, was cloned into pUC1318 (20) to yield pRAL 6054. The 1.1-kb BamHI-SacII fragment from pRAL3244, containing the DNA located 5' of the virG gene, was cloned into pIC19R digested with BglII and NruI, which resulted in pRAL6OSS. The kanamycin resistance gene (aphII) from pHP45Q-Km (6) was isolated as a 1.5-kb HindIII fragment.
The HindIII sites were filled in with Klenow enzyme, and this fragment was cloned into the EcoRV site of pBR322, resulting in pRAL6056. The 1.15-kb EcoRI-HindIII fragment from pRAL6055, containing the DNA located 5' of the virG gene, was cloned into pRAL6056, yielding pRAL6057. The 1.0-kb BamHI fragment from pRAL6054, containing the DNA located 3' of the virG gene, was cloned into the BamHI site of pRAL6057, which resulted in pRAL6058. Plasmid pRAL6058 contains the sequences flanking the virG gene separated by the aphII gene. This plasmid was introduced into LBA1165, which contains the wild-type pTi15955 plasmid in an LBA288 background strain. After selection for kanamycin resistance and carbenicillin sensitivity (indicative of a replacement of the virG gene by aphII), these strains were checked by Southern blot EcoRI-KpnI fragments were treated with hydrazine, formic acid, and sodium nitrite. Double-stranded (ds) DNA was generated with Taq DNA polymerase by PCR using the primers GpcrI and GpcrII (Fig. 2 ), which are indicated by arrows. The mutagenized virG fragments were subcloned in a WHR vector and introduced into the A. tumefaciens virG deletion strain LBA2602 for a ,3-galactosidase assay.
hybridization for the replacement of the virG gene by the aphII gene. One strain containing the correct replacement was called LBA2600, containing Ti plasmid pAL2600. Plasmid pRAL 3296, containing the virB-lacZ translational fusion gene (28), was introduced into LBA2600. Selection for a single-crossover event resulting in a carbenicillin-resistant strain yielded strain LBA2602 with Ti plasmid pAL2602.
Media and antibiotics. Eschenichia coli strains were grown at 370C in LC medium (8) , andAgrobacterium tumefaciens strains were grown at 290C in minimal medium with 10 mM glucose as the carbon source (9) . The induction medium for A. tumefaciens vir induction contained MM-salts, 62.5 mM potassium phosphate (pH 4.8 or 7.0), and 10 mM glucose as the carbon source (28) . Antibiotics were used at the concentrations (micrograms per milliliter) indicated in parentheses: for E. coli strains, carbenicillin (100), kanamycin (25) , spectinomycin (50) , and tetracycline (10); for A. tumefaciens strains, carbenicillin (75), kanamycin (100), rifampin (20) , spectinomycin (250), and tetracycline (2) .
Chemicals. Taq DNA polymerase was purchased from Promega. Other enzymes were purchased from Pharmacia B.L. Biochemical and used as recommended by the supplier. 35S radioisotope-labeled ct-dATP was purchased from Amersham. IPTG (isopropyl-3-D-thiogalactopyranoside), X-Gal (5-bromo-4-chloro-3-indolyl-p-D-galactopyraniside), and ONPG (o-nitrophenyl-B-D-galactopyranoside) were purchased from Sigma Chemical Co. Antibiotics were purchased from Duchefa. Oligonucleotides were obtained from Mogen Int. NV (Leiden, The Netherlands), nucleotides were obtained from Promega Biotec, Inc., formic acid was obtained from Merck, hydrazine was obtained from Serva, and AS was obtained from EGA-Chemie. For PCR, a Sensa 949E DNA processor (Biozym) was used.
Construction of the cassette virG gene. The 1.25-kb BglII-PstI fragment of plasmid pRAL3259 (30) , containing the wild-type virG gene, was cloned into plasmid M13mp8 digested with BamHI and PstI, to yield plasmid pRAL6062. Singlestranded ssDNA of this plasmid was isolated and mutagenized by the method of Carter et al. (4) , using the oligonucleotides Gbgl, Geco, Gkpn, and Gxho (Fig. 2) , to yield pRAL6063, which contains a virG gene with a number of convenient restriction sites. The 1.25-kb SmaI-PstI virG fragment from pRAL6063 was cloned into pIC19R (25) digested with NruI and PstI, which resulted in plasmid pRAL6064. The 1.25-kb SacI-PstI virG fragment from pRAL6064 was cloned into pRL755 digested with Sacl and PstI, resulting in the cassette virG gene on a wide-host-range plasmid, pRAL6065. From pRAL6065, the virG gene was cloned as a 1.28-kb HindIII fragment in two orientations into M13mpl8 digested with HindIII, producing pRAL6066 and pRAL6067. From these two plasmids, ssDNA was isolated from large-scale preparations and purified by a CsCl gradient centrifugation step. These ssDNA samples were used in the mutagenesis experiment.
Mutagenesis. For mutagenesis, ( Fig. 1 ), 10-,ug aliquots of ssDNA of both plasmids pRAL6066 and pRAL6067 were treated separately for 60 min with 1.2 M sodium nitrite, 10 min with 3.6 M or 7.2 M formic acid, and 10 min with 2 M or 4 M hydrazine in a volume of 25 ,ul at room temperature (RT). After treatment, DNA was precipitated and dissolved in 20 ,ul of Tris-EDTA. The individually treated samples were used to amplify the virG gene in a PCR using oligonucleotides Gpcrl and GpcrII ( Fig. 1 and 2) and Taq DNA polymerase under standard PCR conditions (13) . The amplified DNA samples were digested with KpnI, BglII, EcoRI, and XhoI, and the three resulting fragments, BglII-XhoI (BX), XhoI-EcoRI (XE), and EcoRI-KpnI (EK), were isolated. The respective pools of mutant fragments were cloned into the wide-host-range plasmid pRAL6065 to replace the corresponding wild-type fragment. Ligation mixtures were transformed to competent MC1061 cells. Cells were selected on LC medium with spectinomycin and tetracycline. Approximately 3,000 colonies were scraped off the plates for each transformation. Plasmids were isolated from these cells, and these batches of mutant plasmids were used to transform Agrobacterium strain LBA2602, which is deleted for virG. The resulting agrobacteria were screened for an altered phenotype by using the 3-galactosidase enzyme assay. Plasmid DNA was isolated from the mutant bacteria, and the mutations were characterized by sequencing.
Screening and characterization of mutants. Samples of each of the three plasmid batches containing the mutagenized BX, XE, and EK fragments of the virG gene in pRAL6065 were introduced into the Agrobacterium virG deletion strain LBA2602 by electroporation (26) . Bacteria were grown on rich medium and then replica plated onto induction medium containing X-Gal with or without inducer AS to screen for reporter gene expression in the absence of an inducer as well as for an impaired reporter gene expression. After purification of the potential mutants, these were checked for vir induction and then characterized in detail. From these strains, plasmid DNA was isolated and introduced into the E. coli MC1061. The 1.28-kb HindIII fragments from the plasmids containing virG mutant genes were cloned into M13mpl8 digested with HindIII. ssDNA was isolated from these clones, and the nucleotide sequences of the mutant fragments were determined (23). The 1.25-kb SacI-PstI mutant fragments were isolated and cloned into pRL755. The resulting plasmids were This study a 0, Two extra mutations accidentall introduced during mutagenesis by the method of Carter et al. (4) . electroporated into LBA2602, and the resulting strains were rechecked for vir induction to establish a direct correlation between the virG mutation and the mutant phenotype. Phosphorylation assay. The VirA and VirG proteins were purified and used in the phosphorylation experiments as described by Jin et al. (14, 15) . The VirA protein was auto- added to 10 pl of the VirG protein. After 10 min at RT, the reaction was stopped by adding 10 pl of 3X Laenmli loading buffer. The proteins were separated by gel electrophoresis and subsequently transferred to nitrocellulose filters. These membranes were rinsed with water, air dried, and exposed to X-ray film at -800C, using an intensifying screen. After exposure, the filters were stained with Coomassie brilliant blue to visualize the amount of protein used in the reaction.
Gel retardation assay. Two DNA fragments, one containing the virB promoter and one containing the virB promoter from which the putative vir boxes were removed, were labeled with [o-32P]dCTP in a Klenow reaction. These fragments were separated from the free nucleotides by gel electrophoresis and incubated for 30 min at RT with 0.2 pg of the VirG proteins. 
3. Substitutions in the amino acid sequence of the cassette virG gene. The one-letter amino acid code is used for the virG sequence (241 residues). Single-amino-acid substitutions are indicated above the sequence. To create a unique EcoRI site, a valine-toisoleucine substitution at position 119 was introduced. With the method of Carter et al. (4) , two extra mutations were accidentally introduced at positions 236 and 237, from which the wild-type residue is indicated in parentheses. dithiothreitol, and 25% glycerol; 5 ,ug of poly(dI-dC) was used as a nonspecific competitor DNA. The samples were electrophoresed on a 5% polyacrylamide agarose gel; after electrophoresis, the dried gel was exposed to X-ray film at -80°C, using an intensifying screen.
Induction of agrobacteria. Bacteria were grown overnight in minimal medium to an optical density at 600 nm of 0.7 to 0.8. Cells were pelleted by centrifugation and diluted 1:20 in induction medium with different concentrations of AS (0, 0.5, and 100 ,uM) (stock solution in dimethyl sulfoxide). Plasks were shaken for 18 h at 29°C, and ,-galactosidase activity was measured as described by Miller (32) .
Site-directed mutagenesis. The two mutations N54D and 177V were introduced into a wild-type VirG protein by oligonucleotide-mediated site-directed mutagenesis (21) . Therefore, the 1.25-kb BglII-PstI fragment containing the entire virG gene was cloned into the bacteriophage M13mpl9 vector. Uracil-containing ssDNA was prepared in E. coli CJ236 (18) . Oligonucleotides o54 and o77 (Fig. 2 ) were used to generate the N54D and 177V substitutions, respectively. The mutations were confirmed by dideoxy-mediated sequencing reactions (41) . M13mpl9 clones containing the particular mutations were cleaved with EcoRI and PstI to obtain the mutated virG fragments, which were ligated to EcoRland Pstl-cleaved pTZ18R. The resulting constructs with the N54D and. 177V mutations were cleaved with Pstl and cloned into the' IncP wide'-host-range vector pRL755 to yield pRAL631l and pRAL63l2, respectively. As a control, the wild-type virG 'gene was also cloned into the pRL755, resulting in pRAL6305.
These constructs were introduced into A. tumefaciens' LBA 2602 (pTi15955AvirG, VvirB-lacZ), LBA2524 (pTiB6AvirA, virB-lacZ), and LBA2390 (C58IpTiB6806, chvE::TnS) by triparental mating (8) . All strains were tested for tumorigenesis on Kalanc/hce tubifiora and Kalanchoe daigremontiana.
Virulence assay. Agrobacterium strains were grown overnight at 290C on LC agar plates with the necessary antibiotics. K daigremontiana and K tubifiora were grown in the greenhouse for 3 months at 230C. Tumor induction was tested by puncturing the main stem of K daigremontiana and K tubiflora with a needle containing an inoculum of the strain to be tested. All strains were tested three times on three separate plants. After 21 days, plants were scored for tumor formation.
RESULTS AND DISCUSSION
virG cassette vector. To be able to characterize a large number of virG mutants, a cassette virG gene was constructed.
In this gene, which is present on plasmid pRAL6O65, unique EcoRI and Xhol sites are present. Moreover, a BglII site is located in front of the promoter, and a Kpnl site is located 3' of the terminator of the virG gene. The VirG protein encoded by this cassette gene is identical to that of the wild-type virG except that at position 119, a valine residue is changed into an isoleucine (Fig. 3 ). This mutation, however, did not significantly affect the functioning of the VirG protein (see below). Introduction of plasmid pRAL6065 into the Agrobacterium virG deletion mutant LBA2602 restored its ability to induce tumors on Nicotiana glauca plants (data not shown). When this strain was used in a ,B-galactosidase assay, the maximum induction level was 70% of the wild-type level. This means that this virG gene can be used in the screening procedure for mutants with an impaired capacity to activate the reporter gene.
Mutagenesis. To obtain virG mutations, we followed the protocol of Myers (33) and used ssDNA of plasmids pRAL 6066 and pRAL6067. However, in contrast to the procedure of Myers, our DNA samples were treated with a cocktail of three mutagens, i.e., hydrazine, formic acid, and sodium nitrite, so as to obtain as many different mutations as possible. The treated samples of ssDNA were used to obtain a 1,035-bp doublestranded DNA fragment via PCR. The amplified DNA was digested with BglII, XhoI, EcoRI, and KInI, and the individual BX, XE, and EK fragments were cloned separately into pRAL6O65 to replace the wild-type virG fragment. Thereafter, pools of mutant plasmids were transferred to the virG deletion mutant LBA2602. Of 570 Agrobacterium transformants tested on vir-inducer-containing indicator plates, 110 gave white or light blue instead of dark blue colonies. Of these, 29% contained one single-base-pair substitution and 6% contained two-base-pair substitutions in the virG gene, as revealed by sequencing. As many as 90% of the substitutions were transitions (A<-*G or C<->T), and the remaining 10% were transversions. The mutations that led to reduced capacity to activate the reporter gene were distributed randomly over the gene (Fig. 3 ). All of these mutations show less than 10% of the wild-type level of activity (not shown). Closer inspection of these inactive mutants shows that the mutations V51A and L53P are located close to the active site of the protein, which suggests that these mutations may affect the phosphorylation process. Sequence homology studies within the CheY family of bacterial signal transduction proteins revealed that certain residues are specifically conserved (48) . It is plausible that mutations in these conserved residues affect the activity of the protein. This is probably the reason that the mutants with mutations LSP, L41P, L92Q, G95R, I1OOT, F104S, and F109S, which are all in conserved residues, show an impaired capacity to activate the virB-lacZ reporter gene. On the basis of the crystal structure of the CheY protein (45, 49) , a model of the N-terminal domain of VirG was built (39) . This model showed that the M13 residue is located in the. active site of the protein and probably stabilizes the protein together with the conserved K102 residue. It is therefore likely that mutation M13V affects the stability of the protein. Indeed the mutant with the M13V mutation produces an unstable protein (unpublished observations). The remaining mutations in the N-terminal part of the VirG protein, R14C, E19K A25V, R39T, A44T, I63T, V641, R65H, 175T, S97G, LllOP, VllSA, and A116V, may affect its capacity to become phosphorylated. However, none of the N-terminal mutant proteins tested was completely defective in in vitro phosphorylation by the VirA protein (data not shown). However, it may be that a difference in the kinetics of the phosphorylation reaction underlies the defectiveness of some of these mutant VirG proteins.
Mutations in the C-terminal domain of the VirG protein which are inactive may be disturbed in their DNA-binding capacity. This could be valid for mutants with the W137R, L156P, T157A, D173H, L175P, S184G, R194K, V198M, 1200T, E208G, D210Y, Y225C, F226S, Q232G, S234P, and M239V mutations, which are located in the putative DNAbinding domain as defined by Powell and Kado (38) . Gel retardation experiments were done with a number of these purified mutant proteins. While the S184G, D210Y, S234P, and M239V mutant proteins were still able to provoke a DNA band shift, the L156P, R194K, and E208G proteins were defective in binding to vir box DNA ( Fig. 4 ). For these mutant proteins, the experiment was repeated with more protein (0.5 jig), but still no DNA band shift was observed. In addition, the L156P and E208G mutant proteins are also defective in phosphorylation by the VirA protein (data not shown). Because all mutant proteins are isolated and renaturated in one experiment under the same conditions, it is unlikely that the inactivity of the L156P and E208G mutant proteins is the result of an inactive preparation of the protein. Therefore, we assume that the L156P and E208G mutant proteins are defective in both the phosphorylation and the DNA-binding reaction.
Basic residues such as R194 may provide base specific contacts or nonspecific phosphate backbone contacts. As arginine 194 cannot functionally be replaced by lysine, it is more likely that R194 is part of a region providing for base specific interactions.
Screening for inducer-independent VirG mutants. By screening the mutant library for inducer-independent mutants, we found two mutants which were able to activate the virB-lacZ reporter gene in the absence of AS. These mutants were selected on solid minimal medium agar plates (pH 5.3) con- taining X-Gal. On such plates, in which AS was absent, two blue colonies were found. Sequence analysis of the two virG mutants showed that the altered phenotype of the two mutants was caused by a single-base-pair substitution in the virG gene, which led to the amino acid substitutions asparagine to aspartate at position 54 (N54D) and isoleucine to valine at position 77 (M77V). To exclude the possibility that the effects seen were due to a combination of these mutations with the V1191 mutation already present, these two mutations were separately introduced into a wild-type VirG protein by oligonucleotidemediated site-directed mutagenesis (21) . The resulting constructs, pRAL6311 (coding for virGN54D) and pRAL6312 (coding for virGI77V), were introduced into LBA2602 for characterization. Tumorigenesis on K tubiflora and K daigremontiana showed that both the virGN54D and virGI77V genes were capable of restoring tumorigenicity of the Agrobactenium virG deletion mutant LBA2602 (data not shown). A ,-galactosidase assay showed that the VirGN54D protein is capable of activating vir gene transcription efficiently in the absence of AS (Table 2 ). However, the system remains partially inducible by AS, as seen by the increase of the induction level at higher AS concentrations. To be able to induce vir genes, a low pH is required by VirGN54D (5, 24) . At pH 6.9, there is almost no vir induction by this mutant protein. This finding is in agreement with the results of Jin et al. (17) , who found a severely reduced activity of a similar mutant at pH 7.0, but are in contrast with the observations published by Han et al. (7) and Pazour et al. (37) . Strain differences as well as small differences in the origin of the virG gene may account for this discrepancy. When tested in liquid culture, the virGI77V mutant unexpectedly exhibited almost no induction in the absence of the inducer AS but was supersensitive to low concentrations of AS.
At a concentration of only 0.5 ,uM AS, there was vir expression at near-maximal levels ( Table 2) . Interestingly, this mutant still exhibits a significant level of vir induction at pH 6.9 if 100 pLM AS is present in the medium (Table 2 ). This particular mutation was possibly found as an AS-independent mutant on solid agar plates because of the high sensitivity of the plate assay or the possible presence of low concentrations of phenolic vir inducers in the agar.
It was of interest to examine whether the two mutant VirG proteins were still dependent on VirA. Therefore, plasmids pRAL6311 and pRAL6312 were introduced into the virA deletion strain LBA2524. Tumorigenesis on K tubiflora and K daigremontiana (Fig. 5 ) showed that the virA mutant was rendered tumorigenic by acquisition of the virGN54D gene but not by extra copies of the wild-type virG gene. Similar results were published previously by others (7, 17, 37) . The presence of the virGI77V gene, however, could not suppress the avirulent phenotype of the virA mutant. The chvE mutation in LBA2390 results in a limited host range for tumorigenesis (11) . We found that chvE mutants are avirulent on K daigremontiana ( Fig. 6B ) but virulent on K tubiflora (Fig. 6A ). The introduction of extra copies of a wild-type virG gene in the chvE mutant LBA2390 did not lead to an extension of the host range. However, derivatives of LBA2390 provided with the virGN54D or virGI77V genes were able to provoke tumor formation on K daigremontiana (Fig. 6 ). This result was expected for the derivative with the VirGN54D gene, since this mutation makes the strain independent of virA and thus independent of chvE in tumorigenesis. The VirGI77V mutant, however, which is responsive to low concentrations of AS via the VirA protein, thus turns out to be independent of the sugar enhancement via ChvE. The fact that the VirGI77V mutation is sensitive to low concentrations of AS is probably the reason that this strain is infectious on K daigremontiana. The AS concentration in this plant is probably very low but apparently high enough for the VirGI77V mutant to cause tumor formation. According to the results in Table 2 , the VirGI77V mutant protein can induce vir genes even at low AS concentrations and at neutral pH in the presence of high AS levels. Nevertheless, this mutant VirG protein is still dependent on VirA. It is likely that the phosphorylation activity of VirA is severely diminished (30, 37) at low AS concentrations and at pH 6.9. The VirGI77V mutation seems to compensate for such limited levels of VirA phosphorylation activity. Therefore, either the VirGI77V protein may have a higher affinity for VirA and become phosphorylated more efficiently, or its phosphorylated form may be more stable and have a longer half-life. In vitro phosphorylation experiments showed that the VirGI77V protein is efficiently phosphorylated by VirA but that the VirGN54D protein is only poorly phosphorylated ( Fig.  7) . Further in vitro and in vivo phosphorylation assays will have to be done to study the kinetics of the phosphorylation reaction and the stability of the phosphorylated proteins. This mutant as well as the VirGN54D mutant may become useful in plant transformation experiments in which higher pH conditions are required or for transformation of plants which produce limiting levels of inducers.
